HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cybulsky, I. J. Articles by Roth, J. A. Search for Related Content PubMed PubMed Citation Articles by Cybulsky, I. J. Articles by Roth, J. A.

The Annals of Thoracic Surgery, Vol 54, 533-537, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Prognostic significance of computed tomography in resected N2 lung cancer

IJ Cybulsky, LA Lanza, MB Ryan, JB Putnam Jr, MM McMurtrey and JA Roth
Department of Thoracic Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030.

We reviewed 124 patients from 1982 to 1988 who had a resected primary non-small cell lung cancer metastatic to mediastinal (N2) lymph nodes and a preoperative assessment of the mediastinum with computed tomography of the chest. Sixty-three patients studied had computed tomographic evidence of mediastinal lymph node enlargement. In these patients the survival at 5 years was only 6.6%, compared with the 5- year survival of 13.5% in 61 patients in whom the mediastinum was normal. Plain chest roentgenography with evidence of mediastinal adenopathy did not predict a poorer outcome. In addition, patients with tumors located in the left upper lobe were found to have an improved survival. These patients had a 5-year survival of 20.8%. Tumor histology, central location of the tumor, extranodal extension, and type of resection did not result in a significant survival difference.

This article has been cited by other articles:

				P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The significance of one-station n2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630. [Abstract] [Full Text] [PDF]

				M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824. [Abstract] [Full Text] [PDF]

				P. Misthos, E. Sepsas, K. Athanassiadi, S. Kakaris, and I. Skottis Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 502 - 508. [Abstract] [Full Text] [PDF]

				J.A. Verschakelen, J. Bogaert, and W. De Wever Computed tomography in staging for lung cancer Eur. Respir. J., February 1, 2002; 19(35_suppl): 40S - 48s. [Abstract] [Full Text] [PDF]

				J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]

				D. OST and A. FEIN Evaluation and Management of the Solitary Pulmonary Nodule Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 782 - 787. [Full Text]

				F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989. [Abstract] [Full Text] [PDF]

				F. Tanaka, K. Yanagihara, Y. Otake, R. Miyahara, Y. Kawano, T. Nakagawa, T. Shoji, and H. Wada Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend Eur. J. Cardiothorac. Surg., August 1, 2000; 18(2): 147 - 155. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]

				K. Takamochi, K. Nagai, J. Yoshida, K. Suzuki, Y. Ohde, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE ROLE OF COMPUTED TOMOGRAPHIC SCANNING IN DIAGNOSING MEDIASTINAL NODE INVOLVEMENT IN NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1135 - 1140. [Abstract] [Full Text] [PDF]

				K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153. [Abstract] [Full Text] [PDF]

				K. Suzuki, K. Nagai, J. Yoshida, E. Moriyama, M. Nishimura, K. Takahashi, and Y. Nishiwaki Prognostic factors in clinical stage I non-small cell lung cancer Ann. Thorac. Surg., April 1, 1999; 67(4): 927 - 932. [Abstract] [Full Text] [PDF]

				K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki CLINICAL PREDICTORS OF N2 DISEASE IN THE SETTING OF A NEGATIVE COMPUTED TOMOGRAPHIC SCAN IN PATIENTS WITH LUNG CANCER J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 593 - 598. [Abstract] [Full Text] [PDF]

				J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, and M. Demedts Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]

				R. Nakanishi, T. Osaki, K. Nakanishi, I. Yoshino, T. Yoshimatsu, H. Watanabe, H. Nakata, and K. Yasumoto Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 1997; 64(2): 342 - 348. [Abstract] [Full Text]

				J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450. [Abstract] [Full Text]

				D. J. Sugarbaker, J. Herndon, L. J. Kohman, M. J. Krasna, M. R. Green, t. C. a. L. G. B T. S. Group, and S. b. V. Rusch Results of cancer and leukemia group B protocol 8935A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 473 - 485. [Abstract] [Full Text]

				R. Rosell, J. Gomez-Codina, C. Camps, J. Maestre, J. Padille, A. Canto, J. L. Mate, S. Li, J. Roig, A. Olazabal, et al. A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer N. Engl. J. Med., January 20, 1994; 330(3): 153 - 158. [Abstract] [Full Text]